There is nothing right now that says SGH can comfortably meet significant convertible note payments. Even normalised cashflow was barely positive and in decline.
Please specify where you get that information from?
EBITDAW - normalised H1 F17 was AUD 7.8mil positive
EBITDAW - normalised H1 F16 was AUD 14.8mil negative
An improvement of approx AUD 22mil.
That is even when we were in the middle of restructuring and performance improvement plans.
When that is over it is very likely that we will obtain even more healthy positive cash flows.
Any input is appreciated but please be honest as you may mislead innocent investors who would like to get in at these prices
Buying SGH, page-401
-
- There are more pages in this discussion • 54 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)